Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.79
(-1.56%)
CNY 3.79
(-1.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.43 Billion CNY | -6.02% |
| 2022 | 8.97 Billion CNY | -2.55% |
| 2021 | 9.21 Billion CNY | 104.72% |
| 2020 | 4.49 Billion CNY | 193.09% |
| 2019 | 1.53 Billion CNY | 23.73% |
| 2018 | 1.24 Billion CNY | 65.13% |
| 2017 | 751.35 Million CNY | 95.12% |
| 2016 | 385.07 Million CNY | 63.96% |
| 2015 | 234.85 Million CNY | 27.56% |
| 2014 | 184.11 Million CNY | 220.2% |
| 2013 | 57.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7.87 Billion CNY | -4.39% |
| 2024 Q1 | 8.23 Billion CNY | -2.38% |
| 2024 Q3 | 6.81 Billion CNY | -43.55% |
| 2023 Q4 | 8.43 Billion CNY | -2.38% |
| 2023 Q2 | 8.88 Billion CNY | -0.02% |
| 2023 Q1 | 8.89 Billion CNY | -0.96% |
| 2023 FY | 8.43 Billion CNY | -6.02% |
| 2023 Q3 | 8.64 Billion CNY | -2.78% |
| 2022 Q1 | 9.8 Billion CNY | 6.49% |
| 2022 FY | 8.97 Billion CNY | -2.55% |
| 2022 Q4 | 8.97 Billion CNY | 0.08% |
| 2022 Q2 | 9.65 Billion CNY | -1.56% |
| 2022 Q3 | 8.96 Billion CNY | -7.1% |
| 2021 Q2 | 8.13 Billion CNY | 10.97% |
| 2021 Q3 | 8.61 Billion CNY | 5.97% |
| 2021 Q4 | 9.21 Billion CNY | 6.87% |
| 2021 FY | 9.21 Billion CNY | 104.72% |
| 2021 Q1 | 7.32 Billion CNY | 62.9% |
| 2020 Q2 | 2.23 Billion CNY | 13.65% |
| 2020 Q4 | 4.49 Billion CNY | 11.79% |
| 2020 Q3 | 4.02 Billion CNY | 80.38% |
| 2020 FY | 4.49 Billion CNY | 193.09% |
| 2020 Q1 | 1.96 Billion CNY | 27.89% |
| 2019 Q4 | 1.53 Billion CNY | 4.77% |
| 2019 FY | 1.53 Billion CNY | 23.73% |
| 2019 Q2 | 1.36 Billion CNY | 11.1% |
| 2019 Q3 | 1.46 Billion CNY | 7.23% |
| 2019 Q1 | 1.22 Billion CNY | -0.87% |
| 2018 Q2 | 1.13 Billion CNY | 5.55% |
| 2018 FY | 1.24 Billion CNY | 65.13% |
| 2018 Q4 | 1.24 Billion CNY | 2.23% |
| 2018 Q3 | 1.21 Billion CNY | 6.86% |
| 2018 Q1 | 1.07 Billion CNY | 43.21% |
| 2017 FY | 751.35 Million CNY | 95.12% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 520.1 Million CNY | 0.0% |
| 2017 Q3 | 576.35 Million CNY | 10.81% |
| 2017 Q4 | 751.35 Million CNY | 30.36% |
| 2016 Q4 | 385.07 Million CNY | 0.0% |
| 2016 FY | 385.07 Million CNY | 63.96% |
| 2015 FY | 234.85 Million CNY | 27.56% |
| 2014 FY | 184.11 Million CNY | 220.2% |
| 2013 FY | 57.5 Million CNY | 0.0% |